MicroRNA biosensors for detection of glioblastoma.


Journal

Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 10 12 2023
revised: 10 02 2024
accepted: 11 02 2024
medline: 18 3 2024
pubmed: 15 2 2024
entrez: 14 2 2024
Statut: ppublish

Résumé

Glioblastoma (GBM) is the most common type of malignant brain tumor.The discovery of microRNAs and their unique properties have made them suitable tools as biomarkers for cancer diagnosis, prognosis, and evaluation of therapeutic response using different types of nanomaterials as sensitive and specific biosensors. In this review, we discuss microRNA-based electrochemical biosensing systems and the use of nanoparticles in the evolving development of microRNA-based biosensors in glioblastoma.

Identifiants

pubmed: 38355000
pii: S0009-8981(24)00070-6
doi: 10.1016/j.cca.2024.117829
pii:
doi:

Substances chimiques

MicroRNAs 0
Biomarkers, Tumor 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

117829

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mehdi Fattahi (M)

Institute of Research and Development, Duy Tan University, Da Nang, Vietnam; School of Engineering & Technology, Duy Tan University, Da Nang, Vietnam.

Mohadese Maghsudlu (M)

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Masoumeh Razipour (M)

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Ahmad Movahedpour (A)

Behbahan Faculty of Medical Sciences, Behbahan, Iran.

Mohsen Ghadami (M)

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Mehdi Alizadeh (M)

Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Seyyed Hossein Khatami (SH)

Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mortaza Taheri-Anganeh (M)

Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran.

Ehsan Ghasemi (E)

Abadan University of Medical Sciences, Abadan, Iran.

Hassan Ghasemi (H)

Abadan University of Medical Sciences, Abadan, Iran. Electronic address: medical.bitechnology2@yahoo.com.

Saleh Aiiashi (S)

Abadan University of Medical Sciences, Abadan, Iran. Electronic address: s.aiiashi65@gmail.com.

Elham Ghadami (E)

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: medical.bitechnology3@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH